Dayatan, Jenalyn .

HRN: 27-73-81  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2025
CEFUROXIME 1.5GM (VIAL)
10/12/2025
10/13/2025
IV
1.5 Grams
Every 8 Hours
S/P Diagnostic Curettage And Cervical Punch Biopsy
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: